Asia Pacific Lancet and Pen Needles Market 2023: Key Players by Novo Nordisk, Ypsomed, Terumo Co, Artsana S.p.A.

Lancet and pen needles are extensively utilized for the monitoring, diagnosis, and medication of several diseases such as diabetes and osteoporosis. The increasing prevalence of diabetes and osteoporosis within the Asia Pacific region majorly drives the market growth. In 2016, a study was conducted by the American Diabetes Association, which stated that about 80% of the diabetic patients resides in the developing countries.

The Asia Pacific Lancet and Pen Needles Market is expected to grow at a CAGR of 6.5% during the forecast period 2018-2023.

It was also estimated that the rise of type 2 diabetes in South Asia may grow by over 150% from 2000 to 2035. Moreover, in the Western Pacific region, the number of diabetic patients is expected to rise to 201.8 million by 2035. Additionally, according to the International Osteoporosis Foundation by 2050, over ~50% of all osteoporotic hip fractures are projected occur in Asia. Additionally, increasing geriatric population and growing healthcare expenditure along with favorable government policies may boost the market growth during the forecast period. However, the need to remove the pin after a single use and the high cost as compared to the insulin vials may restrain the market growth during the forecast period.

Key Players

Some of the key players in the Asia Pacific lancet and pen needles market are BD. (U.S.), Novo Nordisk A/S (Europe), Ypsomed (Europe), B. Braun Melsungen AG (Europe), HTL-STREFA (Europe), Terumo Corporation (Asia Pacific), Artsana S.p.A. (Europe), Owen Mumford Ltd. (Europe), and others.

Get a Brochure of This Report @ https://www.marketresearchfuture.com/sample_request/630 .

Segmentation

The Asia Pacific lancet and pen needles market is segmented on the basis of therapy, gauge, needle length, and end users.

On the basis of the therapy, the market is segmented into insulin, glucagon-like peptide-1 (GLP-1), growth hormones, and others.

On the basis of the gauge, the market is categorized into 17/18G, 21G, 23G, and others.

On the basis of the needle length, the market is segmented into 4mm, 8mm, 12mm, and others.

On the basis of end users, the market is segmented into hospitals & clinics, medical institutions & research organizations, and others.

Regional Analysis

On the regional basis, Asia Pacific is segmented into Japan, India, China, the Republic of Korea, Australia, and the Rest of Asia Pacific.

Japan holds a major share of the market followed by the Republic of Korea and Australia owing to the well-developed healthcare sector and high per capita healthcare expenditure. In 2014, according to the Statistics Bureau, Japan’s total medical care expenditure was about 11.20% of the national income, which accounted for USD 0.37 trillion. Additionally, favorable governmental policies boost the market growth in these regions.

Grab Attractive Discount @ https://www.marketresearchfuture.com/check-discount/630 .

China and India have a growing market due to huge population base, increasing demand for the better quality products, rapidly changing the economy, increasing healthcare expenditure, and rising number of pharmaceutical & biotechnological companies. Moreover, increasing number of healthcare organizations like a hospital, the private research institute has led to increasing in the market in India. Rest of Asia Pacific holds the least share of the market.

…Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.